These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25053597)

  • 1. Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Kim YH; Jung WH; Koo JS
    Tumour Biol; 2014 Oct; 35(10):10381-93. PubMed ID: 25053597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Cha YJ; Kim YH; Cho NH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(6):3389-98. PubMed ID: 25031766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Cha YJ; Jung WH; Cho NH; Koo JS
    Yonsei Med J; 2015 May; 56(3):598-607. PubMed ID: 25837163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
    Cha YJ; Kim HM; Koo JS
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of DNA methylation-related proteins in invasive lobular carcinoma of breast: comparison to invasive ductal carcinoma.
    Cha YJ; Kim HM; Koo JS
    Histol Histopathol; 2017 Nov; 32(11):1175-1185. PubMed ID: 28111737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
    Park CK; Jung WH; Koo JS
    Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.
    Sun WY; Kim HM; Jung WH; Koo JS
    J Transl Med; 2016 Jun; 14(1):168. PubMed ID: 27277113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
    BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
    Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
    World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status.
    Ameli F; Rose IM; Masir N
    Asian Pac J Cancer Prev; 2015; 16(6):2385-90. PubMed ID: 25824769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
    Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of metabolism-related proteins in triple-negative breast cancer.
    Kim MJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(1):301-12. PubMed ID: 24427351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status.
    Xiao Y; Ma D; Ruan M; Zhao S; Liu XY; Jiang YZ; Shao ZM
    Sci Rep; 2017 Sep; 7(1):10380. PubMed ID: 28871133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
    Nakagawa S; Miki Y; Miyashita M; Hata S; Takahashi Y; Rai Y; Sagara Y; Ohi Y; Hirakawa H; Tamaki K; Ishida T; Watanabe M; Suzuki T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2016 Jan; 155(1):65-75. PubMed ID: 26715212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.